SynBioBeta

SynBioBeta 2027 Super Early Bird pricing is available through Friday, June 15. Join the AIxBio founders, biopharma leaders, investors, and startups building the future of biology. Presenting sponsor: Pumpkinseed May 3–6, 2027 | San Jose, CA Lock in your pass early. syntheticbiologysummit.com/2027/early-bird

🧬🔬 Week 29 of 2026, 15 Bay Area Bio-economy events 🧫🌱 (7 of which are virtual) 🧵

If you have questions you would like answered about the China Bio-econonomy, please share them with our correspondent @AaronBlotnick as @johncumbers and @SynBioBeta travel to China in the coming weeks.

@OlleSciFi @dancinflo Very cool @OlleSciFi! You should check out @ZBioticsCompany if you are interested in that type of thing.

Great point — synthetic biology is moving far beyond just drug discovery. Here's a concrete example: designing stable gut bacteria as "living pharmacies" that produce therapeutic molecules on demand (Vitamin K2, anti-inflammatory capsinoids) with smart logic gates and containment. Part 2 of the blueprint: olle1976.substack.com/p/programmable… Curious what the SynBioBeta community thinks about the timeline and challenges (especially evolutionary stability).

We are Excited about SynBioBeta's focus on applying technical advances beyond drug discovery. The bio-economy is growing, with synthetic biology applications emerging in everything from cosmetics to food. #SynBio #BioEconomy #Innovation

@sciqst @Merck @abbvie @EliLillyandCo @pfizer @bmsnews @sciqst Glad you found it interesting! Consider subscribing to our newsletter for a deeper dive into biotechnology's role in medicine and ecology: synbiobeta.com/signup

The scrutiny of clinical trials in regions like Xinjiang raises important ethical and security questions. How do you think these investigations will impact global pharmaceutical collaborations moving forward? It's crucial to ensure transparency and ethical governance in multinational trials. For a comprehensive review of such biomedical topics, check out Sci-Quest: a platform designed for exploring detailed scientific insights. #Medicine #ClinicalTrials sciqst.com

A U.S. House committee has opened national security investigations into China clinical trials involving @Merck, @abbvie, @EliLillyandCo, @pfizer, and @bmsnews. Lawmakers are scrutinizing trial sites in Xinjiang and military hospitals, with company responses requested by July 17. reuters.com/world/us-house… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬syntheticbiologysummit.com/2027/early-bir…

@sciqst @AsimovBio @alectricity @sciqst Glad you found it interesting! Consider subscribing to our newsletter for a deeper dive into biotechnology's role in medicine and ecology: synbiobeta.com/signup

That's an exciting development from @AsimovBio! The potential for Chrysalis to improve cell recovery and produce stable, high-titer biotherapeutics could be a game-changer in synthetic biology. How do you think Chrysalis compares with other transposase systems in terms of efficiency and scalability? This could potentially impact biotech research across various fields. #SyntheticBiology #Biotech For those with questions on biotherapeutics or synthetic biology, Sci-Quest is a one-stop platform for every biomedical inquiry, generating comprehensive reviews to assist research: sciqst.com.

From butterfly genomes to biotherapeutics production: @AsimovBio launched Chrysalis, a proprietary transposase built for stronger transgene integration, faster cell recovery, and stable expression. Led by @alectricity, Chrysalis has shown >12 g/L clonal titers and stability beyond 60 generations. globenewswire.com/news-release/2… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/2027/early-bir…

@sciqst @InSilicoMeds @biogerontology @sciqst Glad you found it interesting! Consider subscribing to our newsletter for a deeper dive into biotechnology's role in medicine and ecology: synbiobeta.com/signup

This is indeed a significant milestone in AI-driven drug discovery. The progression to a Phase III trial highlights the promising potential of AI to innovate and accelerate the development of novel therapeutic solutions. How do fellow researchers view the role of AI in transforming traditional drug development pipelines? #AI #DrugDiscovery #Biotech

AI-discovered. AI-designed. Now in Phase III. @InSilicoMeds has initiated a Phase III trial for Rentosertib, its potentially first-in-class oral TNIK inhibitor for idiopathic pulmonary fibrosis. Led by @biogerontology, the 320-patient study marks a major milestone for AI-driven drug development. insilico.com/news/xmjsn4l09… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/2027/early-bir…

@sciqst @sciqst Glad you found it interesting! Consider subscribing to our newsletter for a deeper dive into biotechnology's role in medicine and ecology: synbiobeta.com/signup

The open-sourcing of Waypoint by Outpost Bio is a promising step in helping the scientific community decode complex interactions in microbiomes. Such models can offer new insights into our understanding of health and disease mechanisms. Have there been any efforts to integrate AI or machine learning directly with this model to further enhance its predictive capabilities? #SynBio #Microbiome #Medicine

Outpost Bio is open-sourcing Waypoint, its first microbiome foundation model. Led by Jenny Yang, the release gives researchers open weights, code, datasets and benchmarks to better decode how microbial communities shape health, disease, drug response and nutrition. outpost.bio/perspectives/w… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/2027/early-bir…

@sciqst @sciqst Glad you found it interesting! Consider subscribing to our newsletter for a deeper dive into biotechnology's role in medicine and ecology: synbiobeta.com/signup

This is a fascinating initiative! The fusion of biotech with ecological restoration has immense potential to revive ecosystems. How are SilvaBio and Foray Bioscience ensuring genetic diversity in this restoration process to avoid long-term ecological issues? For a deeper dive into biotechnology's role in medicine and ecology, check out Sci-Quest, a one-stop platform for biomedical inquiries capable of generating detailed reviews: sciqst.com. #Biotechnology #Ecology #Medicine

A keystone tree comeback, powered by biotech. SilvaBio and Foray Bioscience are partnering to scale American chestnut restoration, pairing blight-tolerant breeding with fabricated seed technology to help bring the species back from functional extinction. accessnewswire.com/newsroom/en/bi… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/2027/early-bir…

Just in case it hasn't been said before, most VCs say no the first time they see your deck. Thats usually because these types of investor relations take years to build. Over time, the no's shape the company into being more venture backable; for better and for worse.

@64xbio is moving into lentiviral vector production with LV Apex Suite. Led by @lexrovner, the launch expands 64x Bio’s CellMap-driven VectorSelect platform beyond AAV, targeting productivity and scalability bottlenecks in cell and gene therapy manufacturing. businesswire.com/news/home/2026… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/2027/early-bir…

Biology is moving into mining. A new white paper from Forbion BioEconomy, Bidra Innovation Ventures, Nucleus Capital and World Fund maps how microbes, plants, proteins and fungi could unlock critical minerals. Companies like Endolith, Genomines, @allonniabio, @novonesis and Nuton by @RioTinto show the field moving toward real deployment. forbion.com/news-insights/… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/2027/early-bir…

@scribetx is preparing an IPO to fund its lipid-lowering genetic medicines pipeline. Led by @BenjaminLOakes, Scribe is advancing STX-1150, a first-in-human epigenetic silencing therapy designed to target PCSK9 and durably lower LDL-C without permanently altering DNA. fiercebiotech.com/biotech/scribe… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/2027/early-bir…

@zymecompany has raised a $4M Series A led by Planetary Technologies to scale enzyme biomanufacturing for turf management and agricultural residue management. The round supports manufacturing expansion, field validation, and broader commercialization of products like ThatchZyme. zymecompany.com/zymeco-raises-… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/2027/early-bir…

A synthetic cell, built from defined parts. @KateAdamala and the @UMNews team developed SpudCell, a bottom-up synthetic cell that can express proteins, grow, divide, and undergo selection. Now @Bioticorg, co-founded with @DrewEndy, @JedryszekJan and Chris Raggio, is building it into open infrastructure for synthetic cell engineering. synbiobeta.com/read/the-cell-… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/2027/early-bir…

Fruit flies, but make it biomanufacturing. @futurefieldsHQ is using Drosophila melanogaster as a whole-insect bioreactor for hard-to-express proteins through its EntoEngine platform. Led by @M_AndersonBaron, the company is targeting faster scale-up for cell therapy, IVD, and biopharma protein needs. synbiobeta.com/read/why-flies… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/2027/early-bir…

@ZBioticsCompany has sold 15M+ Pre-Alcohol shots since launching in 2019 and is now expanding into gut health with Sugar-to-Fiber. The profitable San Francisco startup is turning genetically engineered probiotics into consumer products, with retail growth and international markets ahead. agfundernews.com/zbiotics-takes… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬 syntheticbiologysummit.com/2027/early-bir…